In breast cancer, Wang et al. (2018) reported that USP4 facilitates cell proliferation through promoting the stability of HDAC2, whereas Li Y. et al. (2016) found it inhibits cell growth by deubiquitinating PCD4. Here, HDAC2 is linked to breast carcinoma.